Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
SOUMYA CHATTERJEE
🇮🇳
India
Country
🇮🇳
India
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet
Not Applicable
Completed
Conditions
Ischemia
Interventions
Drug: ambrisentan
Subscribe
First Posted Date
2010-02-22
Last Posted Date
2013-05-03
Lead Sponsor
Soumya Chatterjee
Target Recruit Count
20
Registration Number
NCT01072669
Locations
🇺🇸
Nilanjana Bose, Md, Cleveland, Ohio, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy